Myriam Y Hsu

Myriam Y Hsu

Auto-generated profile, based on publicly available information

Myriam Y Hsu

Department of Molecular Biotechnology and Health Sciences Molecular Biotechnology Center University of Torino Turin Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in EMBO Reports
Verified
Journal Article
Open access
PDF file
EWElisabeth Wyart
Elisabeth Wyart
MHMyriam Y Hsu
Myriam Y Hsu
RSRoberta Sartori
Roberta Sartori
EMErica Mina
Erica Mina
VRValentina Rausch
Valentina Rausch
Paolo PorporatoPaolo Porporato
Paolo Porporato
Cachexia is a wasting syndrome characterized by devastating skeletal muscle atrophy that dramatically increases mortality in various diseases, most notably in cancer patients with a penetrance of up to 80%. Knowledge regarding the mechanism of cancer‐induced cachexia remains very scarce, making cachexia an unmet medical need. In this study, we discovered strong alterations of iron metabolism in the skeletal muscle of both cancer patients and tumor‐bearing mice, characterized by decreased iron availability in mitochondria. We found that modulation of iron levels directly influences myotube size in vitro and muscle mass in otherwise healthy mice. Furthermore, iron supplementation was sufficient to preserve both muscle function and mass, prolong survival in tumor‐bearing mice, and even rescues strength in human subjects within an unexpectedly short time frame. Importantly, iron supplementation refuels mitochondrial oxidative metabolism and energy production. Overall, our findings provide new mechanistic insights in cancer‐induced skeletal muscle wasting, and support targeting iron metabolism as a potential therapeutic option for muscle wasting diseases.